Form 8-K - Current report:
SEC Accession No. 0001437749-25-004225
Filing Date
2025-02-18
Accepted
2025-02-18 16:32:54
Documents
14
Period of Report
2025-02-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20250218_8k.htm   iXBRL 8-K 20972
  Complete submission text file 0001437749-25-004225.txt   140747

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pbla-20250212.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20250212_def.xml EX-101.DEF 10353
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20250212_lab.xml EX-101.LAB 13836
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20250212_pre.xml EX-101.PRE 10348
16 EXTRACTED XBRL INSTANCE DOCUMENT pbla20250218_8k_htm.xml XML 2552
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 25635549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)